BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

Professor, I hope you are eluding to the top line HSSD efficacy data in the safety trial.

I did the math on the Bliss safety trial published at the 2800 patient mark and they had 384 patients enrolled on estrogen.

If the ratio remains consistent they should have approx. 501 patients enrolled on estrogen. It will be interesting to see what results these patients produce.

I may be wrong but I believe the efficacy testing in the safety trial has less clinical intervention. If so this may help counter the placebo effect in the bloom trials. Just a thought.